Inventor
BRENNER MICHAEL B
US28 patents
⚠️ This page may combine multiple inventors who share the name “BRENNER MICHAEL B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRIGHAM & WOMENS HOSPITAL
18 patentsUS6300080B1Oct 9, 2001
Methods and compositions for modulating heterotypic E-cadherin interactions with T lymphocytes
BRIGHAM & WOMENS HOSPITAL47 citations94
US5679347AOct 21, 1997
Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods
BRIGHAM & WOMENS HOSPITAL90 citations94
US5610281AMar 11, 1997
Antibodies for modulating heterotypic E-cadherin interactions with human T lymphocytes
BRIGHAM & WOMENS HOSPITAL72 citations94
US5594120AJan 14, 1997
Integrin alpha subunit
BRIGHAM & WOMENS HOSPITAL42 citations94
US6787136B1Sep 7, 2004
Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
BRIGHAM & WOMENS HOSPITAL18 citations91
US6406870B2Jun 18, 2002
Methods and compositions for modulating heterotypic E-cadherin interactions with T lymphocytes
BRIGHAM & WOMENS HOSPITAL17 citations91
US6063906AMay 16, 2000
Antibodies to integrin alpha subunit
BRIGHAM & WOMENS HOSPITAL16 citations91
US6057423AMay 2, 2000
Integrin alpha subunit
BRIGHAM & WOMENS HOSPITAL16 citations91
US6238676B1May 29, 2001
Presentation of hydrophobic antigens to T-cells by CD1 molecules
BRIGHAM & WOMENS HOSPITAL31 citations89
US5853737ADec 29, 1998
Method for inducing a CD1-restricted immune response
BRIGHAM & WOMENS HOSPITAL33 citations89
US5445940AAug 29, 1995
Methods and compositions for detecting and treating a subset of human patients having an autoimmune disease
BRIGHAM & WOMENS HOSPITAL45 citations89
US7488478B2Feb 10, 2009
Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
BRIGHAM & WOMENS HOSPITAL4 citations72
US7029676B2Apr 18, 2006
Methods and compositions for modulating heterotypic E-cadherin interactions with T lymphocytes
BRIGHAM & WOMENS HOSPITAL10 citations72
US6964768B2Nov 15, 2005
Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
BRIGHAM & WOMENS HOSPITAL6 citations72
US6455042B1Sep 24, 2002
Method of treating ulcerative colitis or crohn's disease by administering an antibody toαEβ7 integrin
BRIGHAM & WOMENS HOSPITAL7 citations72
US7063844B2Jun 20, 2006
Presentation of hydrophobic antigens to T-cells by CD1 molecules
BRIGHAM & WOMENS HOSPITAL6 citations70
US7589074B2Sep 15, 2009
Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
BRIGHAM & WOMENS HOSPITAL3 citations61
US7608246B2Oct 27, 2009
Apolipoprotein E as an adjuvant for lipid antigens
BRIGHAM & WOMENS HOSPITAL1 citations43
T CELL SCIENCES INC
5 patentsUS5185250AFeb 9, 1993
Human γ, δT cell antigen receptor polypeptides and nucleic acids
T CELL SCIENCES INC26 citations92
US5601822AFeb 11, 1997
γ, δ T cell receptor and methods for detection
T CELL SCIENCES INC8 citations73
US5340921AAug 23, 1994
Γ, δT cell receptor and methods and detection
T CELL SCIENCES INC9 citations73
US5260223ANov 9, 1993
Methods for detection of human gamma, γ T cell receptor
T CELL SCIENCES INC18 citations73
US5024940AJun 18, 1991
Nucleic acids encoding the delta chain of the T cell antigen receptor
T CELL SCIENCES INC15 citations73
BRIGHAM & WOMENS HOSPITAL INC
2 patentsUS11534496B2Dec 27, 2022
Compositions and methods relating to T peripheral helper cells in autoantibody-associated conditions
BRIGHAM & WOMENS HOSPITAL INC0 citations52
US11097005B2Aug 24, 2021
Use of cadherin-11 antagonists to treat metabolic disorders and/or increase insulin sensitivity
BRIGHAM & WOMENS HOSPITAL INC0 citations50